Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer clinical trials

Explore recruiting recurrent persistent metastatic or locally advanced vulvar cancer clinical trials.

Recruiting recurrent persistent metastatic or locally advanced vulvar cancer studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Pembrolizumab in combination with lenvatinib in patients with recurrent, persistent, metastatic or locally advanced vulvar cancer not amenable to curative surgery or radiotherapy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer trials by city

Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Toronto Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Vancouver Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Montreal Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Calgary Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Edmonton Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Ottawa Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Winnipeg Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Quebec City Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Hamilton Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Kitchener Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in London Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Halifax Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in New York Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Los Angeles Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Chicago Recurrent Persistent Metastatic Or Locally Advanced Vulvar Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease